Wainberg ZA, Enzinger PC, Qin S, Yamaguchi K, Wang J, Zhou X, Gnanasakthy A, Taylor K, Yusuf A, Maher I, Jamotte A, Kang YK. Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer. ESMO gastrointestinal oncology. 2024 Dec;6. doi: 10.1016/j.esmogo.2024.100095
McGinley (Miller) EL, Gabbay RA. The impact of new payment methods on quality of diabetes care and outcomes. Current Diabetes Rep. 2016 Apr 18;16(51). doi: 10.1007/s11892-016-0743-5